Natural Killer Cell (NK cell) Therapy
NK cell therapy uses the body&rsquo;s natural immune cells to target and destroy cancer cells. These cells are either collected from the patient or a donor, expanded in the lab, and then infused back into the patient to boost the immune response. It shows promise for treating cancers like Acute myeloid leukemia, Multiple myeloma, and B-cell NHL.
<a href="https://www.delveinsight.com/report-store/nk-cell-therapy-market">Natural Killer Cell Therapy Market Insights</a>
The&nbsp;Natural Killer Cell Therapy market size in the 7MM is estimated to grow with a significant CAGR during the study period (2020-2034).
Target Patient Pool Analysis
<ul>
<li>Incident Cases in 2023 in the US for Acute myeloid leukemia were ~ 20,000</li>
<li>Incident Cases in 2023 in the US for B-cell NHL were ~70,000 in the US</li>
<li>Incident Cases in 2023 for Multiple myeloma were ~30,000&nbsp;</li>
<li>Incident Cases in 2023 for Non-small cell lung cancer were ~ 200,000&nbsp;</li>
</ul>
&nbsp;
Key Highlights of NK Cell Therapy
<ul>
<li>On November 7, 2024, Indapta Therapeutics presented data on IDP-023, an allogeneic g-NK cell therapy for advanced multiple myeloma and non-Hodgkin lymphoma. The treatment was well-tolerated, with objective responses observed in five of nine patients.</li>
<li>On October 25, 2024, ImmunityBio announced the start of Phase I clinical trial evaluating its CD19-targeted high-affinity natural killer (t-haNK) cell therapy for non-Hodgkin&rsquo;s lymphoma, with the first patients now dosed.</li>
<li>In April 2024, Ingenium Therapeutics announced that its investigational therapy IGNK001 (Gengluecel) has been granted Orphan Drug Designation by the US FDA for the treatment of AML.</li>
</ul>
&nbsp;
Natural Killer Cell (NK cell) Therapy Market Strengths
NK cell therapy has shown significant promise in targeting and destroying various types of cancer cells, demonstrating its potential as an effective treatment option.
&nbsp;
Natural Killer Cell (NK cell) Therapy Market Opportunities
Ongoing clinical trials are refining NK cell therapy techniques, which could lead to improved efficacy and pave the way for future FDA approvals.
&nbsp;
<a href="https://www.delveinsight.com/report-store/nk-cell-therapy-pipeline-insight">Natural Killer Cell (NK cell) Therapy Emerging Drugs and Companies</a>
<ul>
<li>Monalizumab: Innate Pharma</li>
<li>L1 t-haNK: ImmunityBio</li>
<li>M ceNK: ImmunityBio</li>
<li>DF6002: Dragonfly Therapeutics</li>
<li>AlloNK: Artiva Biotherapeutics</li>
</ul>

NK Cell Therapy Infographic Market

NK Cell Therapy Symptoms, Treatment, epidemiology, companies, drugs infographic is a short guide to understand the problem and market landscape.